首页> 外国专利> SERPINE1 polymorphisms are predictive of response to activated protein C administration and risk of death

SERPINE1 polymorphisms are predictive of response to activated protein C administration and risk of death

机译:SERPINE1多态性可预测对活化蛋白C给药的反应和死亡风险

摘要

Methods, oligonucleotides arrays etc. for treating inflammatory conditions and of predicting subject outcome based on polymorphisms in SERPINE1 and/or PROC, alone or in combination, wherein the method of treatment includes administering to the subject an anti-inflammatory agent or an anti-coagulant agent, wherein said subject is determined to have an improved response genotype or combination.
机译:单独或组合用于治疗炎症性疾病和基于SERPINE1和/或PROC中的多态性预测受试者结果的方法,寡核苷酸阵列等,其中治疗方法包括向受试者施用抗炎剂或抗凝剂试剂,其中确定所述受试者具有改善的反应基因型或组合。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号